Combination of 5-fluorouracil and N1,N11- diethylnorspermine markedly activates spermidine/spermine N1- acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells

Woonyoung Choi, Eugene W. Gerner, Latha Ramdas, Jheri Dupart, Jennifer Carew, Lynsey Proctor, Peng Huang, Wei Zhang, Stanley R. Hamilton

Research output: Contribution to journalArticle

Abstract

The thymidylate synthase inhibitor 5-fluorouracil (5-FU) is used widely for chemotherapy of colorectal carcinoma. Recent studies showed that 5-FU affects polyamine metabolism in colon carcinoma cells. We therefore examined whether combinations of 5-FU with drugs that specifically target polyamine metabolism, i.e. N1,N11-diethylnorspermine (DENSPM) or α-difluoromethylornithine (DFMO), have synergistic effects in killing HCT116 colon carcinoma cells with wild-type or absent p53. Our results showed that simultaneous 5-FU and DENSPM, a spermine analogue, synergistically increased transcript levels of the polyamine catabolism enzyme spermidine/spermine N1-acetyltransferase, depleted spermine and spermidine, increased acetylated spermidine, and produced synergistic tumor cell apoptosis in both p53 wild-type and p53-null variants. By contrast, simultaneous combination of 5-FU with DFMO, an inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, depleted putrescine but did not produce synergistic cell killing. Some pre-treatment and post-treatment regimens of DENSPM and DFMO were antagonistic to 5-FU depending on cellular p53 status. Protein and transcriptome expression analysis showed that combined 5-FU and DENSPM treatment activated caspase 9, but not caspase 3, and significantly suppressed NADH dehydrogenases and cytochrome c oxidases, consistent with the observed increase in hydrogen peroxide, loss of mitochondrial membrane potential, and release of cytochrome c. Our findings demonstrate the importance of the polyamine pathway in 5-FU effects and suggest that the combination of 5-FU with DENSPM has potential for development as therapy for colorectal carcinoma.

Original languageEnglish (US)
Pages (from-to)3295-3304
Number of pages10
JournalJournal of Biological Chemistry
Volume280
Issue number5
DOIs
StatePublished - Feb 4 2005
Externally publishedYes

Fingerprint

Acetyltransferases
Spermidine
Spermine
Polyamines
Fluorouracil
Colon
Cells
Apoptosis
Carcinoma
Eflornithine
Metabolism
Colorectal Neoplasms
diamine N-acetyltransferase
NADH Dehydrogenase
Thymidylate Synthase
Ornithine Decarboxylase
Putrescine
Chemotherapy
Caspase 9
Mitochondrial Membrane Potential

ASJC Scopus subject areas

  • Biochemistry

Cite this

Combination of 5-fluorouracil and N1,N11- diethylnorspermine markedly activates spermidine/spermine N1- acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells. / Choi, Woonyoung; Gerner, Eugene W.; Ramdas, Latha; Dupart, Jheri; Carew, Jennifer; Proctor, Lynsey; Huang, Peng; Zhang, Wei; Hamilton, Stanley R.

In: Journal of Biological Chemistry, Vol. 280, No. 5, 04.02.2005, p. 3295-3304.

Research output: Contribution to journalArticle

Choi, Woonyoung ; Gerner, Eugene W. ; Ramdas, Latha ; Dupart, Jheri ; Carew, Jennifer ; Proctor, Lynsey ; Huang, Peng ; Zhang, Wei ; Hamilton, Stanley R. / Combination of 5-fluorouracil and N1,N11- diethylnorspermine markedly activates spermidine/spermine N1- acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells. In: Journal of Biological Chemistry. 2005 ; Vol. 280, No. 5. pp. 3295-3304.
@article{7fc92c24c03546999a69db83471af71e,
title = "Combination of 5-fluorouracil and N1,N11- diethylnorspermine markedly activates spermidine/spermine N1- acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells",
abstract = "The thymidylate synthase inhibitor 5-fluorouracil (5-FU) is used widely for chemotherapy of colorectal carcinoma. Recent studies showed that 5-FU affects polyamine metabolism in colon carcinoma cells. We therefore examined whether combinations of 5-FU with drugs that specifically target polyamine metabolism, i.e. N1,N11-diethylnorspermine (DENSPM) or α-difluoromethylornithine (DFMO), have synergistic effects in killing HCT116 colon carcinoma cells with wild-type or absent p53. Our results showed that simultaneous 5-FU and DENSPM, a spermine analogue, synergistically increased transcript levels of the polyamine catabolism enzyme spermidine/spermine N1-acetyltransferase, depleted spermine and spermidine, increased acetylated spermidine, and produced synergistic tumor cell apoptosis in both p53 wild-type and p53-null variants. By contrast, simultaneous combination of 5-FU with DFMO, an inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, depleted putrescine but did not produce synergistic cell killing. Some pre-treatment and post-treatment regimens of DENSPM and DFMO were antagonistic to 5-FU depending on cellular p53 status. Protein and transcriptome expression analysis showed that combined 5-FU and DENSPM treatment activated caspase 9, but not caspase 3, and significantly suppressed NADH dehydrogenases and cytochrome c oxidases, consistent with the observed increase in hydrogen peroxide, loss of mitochondrial membrane potential, and release of cytochrome c. Our findings demonstrate the importance of the polyamine pathway in 5-FU effects and suggest that the combination of 5-FU with DENSPM has potential for development as therapy for colorectal carcinoma.",
author = "Woonyoung Choi and Gerner, {Eugene W.} and Latha Ramdas and Jheri Dupart and Jennifer Carew and Lynsey Proctor and Peng Huang and Wei Zhang and Hamilton, {Stanley R.}",
year = "2005",
month = "2",
day = "4",
doi = "10.1074/jbc.M409930200",
language = "English (US)",
volume = "280",
pages = "3295--3304",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "5",

}

TY - JOUR

T1 - Combination of 5-fluorouracil and N1,N11- diethylnorspermine markedly activates spermidine/spermine N1- acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells

AU - Choi, Woonyoung

AU - Gerner, Eugene W.

AU - Ramdas, Latha

AU - Dupart, Jheri

AU - Carew, Jennifer

AU - Proctor, Lynsey

AU - Huang, Peng

AU - Zhang, Wei

AU - Hamilton, Stanley R.

PY - 2005/2/4

Y1 - 2005/2/4

N2 - The thymidylate synthase inhibitor 5-fluorouracil (5-FU) is used widely for chemotherapy of colorectal carcinoma. Recent studies showed that 5-FU affects polyamine metabolism in colon carcinoma cells. We therefore examined whether combinations of 5-FU with drugs that specifically target polyamine metabolism, i.e. N1,N11-diethylnorspermine (DENSPM) or α-difluoromethylornithine (DFMO), have synergistic effects in killing HCT116 colon carcinoma cells with wild-type or absent p53. Our results showed that simultaneous 5-FU and DENSPM, a spermine analogue, synergistically increased transcript levels of the polyamine catabolism enzyme spermidine/spermine N1-acetyltransferase, depleted spermine and spermidine, increased acetylated spermidine, and produced synergistic tumor cell apoptosis in both p53 wild-type and p53-null variants. By contrast, simultaneous combination of 5-FU with DFMO, an inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, depleted putrescine but did not produce synergistic cell killing. Some pre-treatment and post-treatment regimens of DENSPM and DFMO were antagonistic to 5-FU depending on cellular p53 status. Protein and transcriptome expression analysis showed that combined 5-FU and DENSPM treatment activated caspase 9, but not caspase 3, and significantly suppressed NADH dehydrogenases and cytochrome c oxidases, consistent with the observed increase in hydrogen peroxide, loss of mitochondrial membrane potential, and release of cytochrome c. Our findings demonstrate the importance of the polyamine pathway in 5-FU effects and suggest that the combination of 5-FU with DENSPM has potential for development as therapy for colorectal carcinoma.

AB - The thymidylate synthase inhibitor 5-fluorouracil (5-FU) is used widely for chemotherapy of colorectal carcinoma. Recent studies showed that 5-FU affects polyamine metabolism in colon carcinoma cells. We therefore examined whether combinations of 5-FU with drugs that specifically target polyamine metabolism, i.e. N1,N11-diethylnorspermine (DENSPM) or α-difluoromethylornithine (DFMO), have synergistic effects in killing HCT116 colon carcinoma cells with wild-type or absent p53. Our results showed that simultaneous 5-FU and DENSPM, a spermine analogue, synergistically increased transcript levels of the polyamine catabolism enzyme spermidine/spermine N1-acetyltransferase, depleted spermine and spermidine, increased acetylated spermidine, and produced synergistic tumor cell apoptosis in both p53 wild-type and p53-null variants. By contrast, simultaneous combination of 5-FU with DFMO, an inhibitor of the polyamine biosynthetic enzyme ornithine decarboxylase, depleted putrescine but did not produce synergistic cell killing. Some pre-treatment and post-treatment regimens of DENSPM and DFMO were antagonistic to 5-FU depending on cellular p53 status. Protein and transcriptome expression analysis showed that combined 5-FU and DENSPM treatment activated caspase 9, but not caspase 3, and significantly suppressed NADH dehydrogenases and cytochrome c oxidases, consistent with the observed increase in hydrogen peroxide, loss of mitochondrial membrane potential, and release of cytochrome c. Our findings demonstrate the importance of the polyamine pathway in 5-FU effects and suggest that the combination of 5-FU with DENSPM has potential for development as therapy for colorectal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=13544265296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13544265296&partnerID=8YFLogxK

U2 - 10.1074/jbc.M409930200

DO - 10.1074/jbc.M409930200

M3 - Article

C2 - 15546879

AN - SCOPUS:13544265296

VL - 280

SP - 3295

EP - 3304

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 5

ER -